Clinical Trials
58 trialsQL1706 Plus Lenvatinib in Previously Treated Penile Cancer
Sun Yat-sen University
LIAM Mc
University College Cork
ANTARES
Instituto do Cancer do Estado de SĂŁo Paulo
DEPECA-2
University Hospital Tuebingen
MH-Penile-002
West China Hospital
MH-Penile-001
West China Hospital
A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer
Fudan University
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Rutgers, The State University of New Jersey
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Rutgers, The State University of New Jersey
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Dana-Farber Cancer Institute
A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
University Health Network, Toronto
Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
Mayo Clinic
PRIAM
The Netherlands Cancer Institute
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
EARN
Washington University School of Medicine
Ivonescimab in the Treatment of Multiple Advanced Tumors
Fudan University
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
BRAVA PENILE
Hospital Israelita Albert Einstein
MEGACEP
UNICANCER
ORPHEUS
MedSIR
CoRe_CC-3
German Cancer Research Center
VELRAD
University College, London
TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer
Sun Yat-sen University
InPACT
Institute of Cancer Research, United Kingdom
PEVOsq
UNICANCER
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
Fudan University
NANOSCAN
The Netherlands Cancer Institute
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
University of Maryland, College Park
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
The Affiliated Hospital of Qingdao University
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
GLANS
University Medical Center Groningen
A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
University of Maryland, College Park
HERCULES
Latin American Cooperative Oncology Group
AcSĂ©
UNICANCER
HARE-40
University of Southampton
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
Dana-Farber Cancer Institute
PERICLES
The Netherlands Cancer Institute
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
The Affiliated Hospital of Qingdao University
Inguinal Lymphadenectomy for Penile Cancer
A.O.U. CittĂ della Salute e della Scienza
PULSE
Centre Hospitalier Universitaire de Besancon
BRUCY
The Christie NHS Foundation Trust
JAVA-P
University Hospitals Bristol and Weston NHS Foundation Trust
Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
University of Alabama at Birmingham
TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer
Sun Yat-sen University
DEDUCER
Helsinki University Central Hospital
Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
Memorial Sloan Kettering Cancer Center
CaptHPV
Institut de Cancérologie de Lorraine
Education, Immigration and HPV Vaccination: an Informational Randomized Trial
Karolinska Institutet
HER-Uro01
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano